209 related articles for article (PubMed ID: 27573774)
1. Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.
Paulson TG
Adv Exp Med Biol; 2016; 908():213-36. PubMed ID: 27573774
[TBL] [Abstract][Full Text] [Related]
2. Genomic alterations in malignant transformation of Barrett's esophagus.
Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H
Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.
Beilstein M; Silberg D
Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity during the development of Barrett's oesophagus-associated adenocarcinoma: how, when and why?
Graham TA; McDonald SA
Biochem Soc Trans; 2010 Apr; 38(2):374-9. PubMed ID: 20298186
[TBL] [Abstract][Full Text] [Related]
5. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.
Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL
Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus: model of neoplastic progression.
Ramel S
World J Surg; 2003 Sep; 27(9):1009-13. PubMed ID: 12917763
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.
Maslyonkina KS; Konyukova AK; Alexeeva DY; Sinelnikov MY; Mikhaleva LM
Cancer Med; 2022 Jan; 11(2):447-478. PubMed ID: 34870375
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
12. Early events during neoplastic progression in Barrett's esophagus.
Reid BJ
Cancer Biomark; 2010; 9(1-6):307-24. PubMed ID: 22112482
[TBL] [Abstract][Full Text] [Related]
13. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
15. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
Walch A; Mueller J; Höfler H; Werner M
J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093
[No Abstract] [Full Text] [Related]
16. Early Barrett's carcinoma of the esophagus.
Hölscher AH; Vallböhmer D; Bollschweiler E
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
[No Abstract] [Full Text] [Related]
17. Neoplastic risk assessment in Barrett's esophagus: How far have we come?
Noffsinger A
Hum Pathol; 2003 Oct; 34(10):965-7. PubMed ID: 14608528
[No Abstract] [Full Text] [Related]
18. Barrett's: do we still need goblet cells for diagnosis?
Lenglinger J; Riegler M
Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
[No Abstract] [Full Text] [Related]
19. Short-segment Barrett's esophagus associated with high-grade dysplasia.
Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
[No Abstract] [Full Text] [Related]
20. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]